107th Congress / Bills / H R 2887
Title
To amend the Federal Food, Drug, and Cosmetic Act to improve the safety and efficacy of pharmaceuticals for children.
Read more information on this bill at the Library of Congress.
Categories (What are categories?)
Administrative procedure | Administrative remedies | Bioethics | Budgets | Business | Child health | Children | Clinical trials | Consumers | Drug adulteration | Drug approvals | Drug industry | Executive departments | Executive reorganization -- Department of Health and Human Services | Families | Foundations | Government information | Government paperwork | Government publicity | Governmental investigations | Human experimentation in medicine | Infants | Informed consent (Medical law) | Intellectual property | Labeling | Law | Medical care | Medical ethics | Medical research | Medicine | Parent and child | Parental consent | Patents | Pediatrics | Pharmaceutical research | Public contracts | Science policy | Social services | User charges
Votes on this bill
| Date | Chamber | Result | Vote |
|---|---|---|---|
| House | Session 1, roll call 444: On Motion to Suspend the Rules and Pass, As Amended Best Pharmaceuticals for Children Act |
